These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21416466)

  • 1. Impact of autoclave sterilization on the activity and structure of formulated heparin.
    Beaudet JM; Weyers A; Solakyildirim K; Yang B; Takieddin M; Mousa S; Zhang F; Linhardt RJ
    J Pharm Sci; 2011 Aug; 100(8):3396-3404. PubMed ID: 21416466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of heparins from different commercial sources.
    Zhang F; Yang B; Ly M; Solakyildirim K; Xiao Z; Wang Z; Beaudet JM; Torelli AY; Dordick JS; Linhardt RJ
    Anal Bioanal Chem; 2011 Nov; 401(9):2793-803. PubMed ID: 21931955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
    Petitou M; van Boeckel CA
    Angew Chem Int Ed Engl; 2004 Jun; 43(24):3118-33. PubMed ID: 15199558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study on the mechanism of the anticoagulant action of mollusc and mammalian heparins.
    Paiva JF; Santos EA; Jeske W; Fareed J; Nader HB; Dietrich CP
    Comp Biochem Physiol A Physiol; 1995 Jul; 111(3):495-9. PubMed ID: 7614042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial one-pot chemoenzymatic synthesis of heparin.
    Bhaskar U; Li G; Fu L; Onishi A; Suflita M; Dordick JS; Linhardt RJ
    Carbohydr Polym; 2015 May; 122():399-407. PubMed ID: 25817684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of pharmaceutical heparins prepared from different animal tissues.
    Fu L; Li G; Yang B; Onishi A; Li L; Sun P; Zhang F; Linhardt RJ
    J Pharm Sci; 2013 May; 102(5):1447-57. PubMed ID: 23526651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of thrombin inactivation by immobilized heparin.
    Byun Y; Jacobs HA; Kim SW
    J Biomed Mater Res; 1996 Apr; 30(4):423-7. PubMed ID: 8847350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants.
    Chen Y; Lin L; Agyekum I; Zhang X; St Ange K; Yu Y; Zhang F; Liu J; Amster IJ; Linhardt RJ
    J Pharm Sci; 2017 Apr; 106(4):973-981. PubMed ID: 28007564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approach for preparation of heparins specific to factor Xa using affinity chromatography coupled with synthetic antithrombin III-related peptides.
    Onoue S; Harada S; Nemoto Y; Yajima T; Kashimoto K
    Peptides; 2003 Jun; 24(6):821-6. PubMed ID: 12948833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms responsible for catalysis of the inhibition of factor Xa or thrombin by antithrombin using a covalent antithrombin-heparin complex.
    Paredes N; Wang A; Berry LR; Smith LJ; Stafford AR; Weitz JI; Chan AK
    J Biol Chem; 2003 Jun; 278(26):23398-409. PubMed ID: 12695507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminal fragment of axon guidance molecule Slit3 binds heparin and neutralizes heparin's anticoagulant activity.
    Condac E; Strachan H; Gutierrez-Sanchez G; Brainard B; Giese C; Heiss C; Johnson D; Azadi P; Bergmann C; Orlando R; Esmon CT; Harenberg J; Moremen K; Wang L
    Glycobiology; 2012 Sep; 22(9):1183-92. PubMed ID: 22641771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity.
    Grootenhuis PD; Westerduin P; Meuleman D; Petitou M; van Boeckel CA
    Nat Struct Biol; 1995 Sep; 2(9):736-9. PubMed ID: 7552742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the COOH-terminal region of antithrombin III. Evidence that the COOH-terminal region of the inhibitor enhances the reactivity of thrombin and factor Xa with the inhibitor.
    Nishioka J; Suzuki K
    J Biol Chem; 1992 Nov; 267(31):22224-9. PubMed ID: 1331047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sulfated fucan from the brown alga Laminaria cichorioides has mainly heparin cofactor II-dependent anticoagulant activity.
    Yoon SJ; Pyun YR; Hwang JK; Mourão PA
    Carbohydr Res; 2007 Nov; 342(15):2326-30. PubMed ID: 17631282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear diffusion of thrombin and factor Xa along the heparin molecule explains the effects of extended heparin chain lengths.
    Wagenvoord R; Al Dieri R; van Dedem G; Béguin S; Hemker HC
    Thromb Res; 2008; 122(2):237-45. PubMed ID: 18045667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-hirudin complex stability: a comparison with the thrombin-antithrombin III complex.
    Römisch J; Pâques EP
    Blood Coagul Fibrinolysis; 1991 Oct; 2(5):643-6. PubMed ID: 1782334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.
    Lane DA; Denton J; Flynn AM; Thunberg L; Lindahl U
    Biochem J; 1984 Mar; 218(3):725-32. PubMed ID: 6721831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the anticoagulant mechanisms of a covalent antithrombin-heparin complex.
    Berry L; Stafford A; Fredenburgh J; O'Brodovich H; Mitchell L; Weitz J; Andrew M; Chan AK
    J Biol Chem; 1998 Dec; 273(52):34730-6. PubMed ID: 9856996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.